IE37942L - Carbazoles - Google Patents

Carbazoles

Info

Publication number
IE37942L
IE37942L IE731252A IE125273A IE37942L IE 37942 L IE37942 L IE 37942L IE 731252 A IE731252 A IE 731252A IE 125273 A IE125273 A IE 125273A IE 37942 L IE37942 L IE 37942L
Authority
IE
Ireland
Prior art keywords
amino
group
lower alkyl
formula
lower alkoxy
Prior art date
Application number
IE731252A
Other versions
IE37942B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE37942L publication Critical patent/IE37942L/en
Publication of IE37942B1 publication Critical patent/IE37942B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1385620 Carbazoles F HOFFMANN-LA ROCHE & CO AG 23 July 1973 [24 July 1972] 34968/73 Heading C2C The invention comprises compounds of the formula wherein R represents a hydrogen or halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono- (lower alkyl)amino, di(lower alkyl)amino, sulphamoyl, di(lower alkyl)sulphamoyl or difluoromethylsulphonyl group and R 1 represents a halogen atom or a hydroxy, cyano, lower alkyl, hydroxy-(lower alkyl), lower alkoxy, acyl, acylamido, benzyloxy, lower alkylthio, trifluoromethyl, carboxy, carbo-(lower alkoxy), nitro, amino, mono(lower alkyl)amino, di- (lower alkyl)amino, sulphamoyl, di(lower alkyl) - sulphamoyl or difluoromethylsulphonyl group or R and R 1 together represent a lower alkylenedioxy group, R 2 represents the grouping in which A represents a cyano, hydroxy, lower alkoxy, amino(lower alkoxy), mono(lower alkyl)- amino-(lower alkoxy), di(lower alkyl)amino- (lower alkoxy) group or the grouping wherein B represents a hydroxy, carboxy, lower alkoxy, amino, hydroxyamino, mono(lower alkyl)amino, di(lower alkyl)amino, amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy), di(lower alkyl)amino - (lower alkoxy) group, Y and X each represent a hydrogen atom or a lower alkyl group and n stands for 1 to 7, and R 3 represents a hydrogen atom or a lower alkyl, acyl, halo-substituted acyl, carboxy- (lower alkyl), (lower alkoxycarbonyl)-(lower alkyl), aralkyl or haloaralkyl group, or R 1 represents a hydrogen atom when R, X and R 3 each represent a hydrogen atom, Y represents a lower alkyl group and B represents a hydroxy or lower alkoxy group, and, when R or R 1 represents a carboxy and/or when B represents a hydroxy or carboxy group, salts thereof with bases and, when R or R 1 represents an amino or mono (lower alkyl)amino or di(lower alkyl)amino group and/or when B or A represents an amino- (lower alkoxy) or mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, addition salts thereof with acids. The term lower alkyl means an alkyl group of 1-7 carbon atoms, acyl means alkanoyl derived from a carboxylic acid containing 1-7 carbon atoms and aryl means phenyl optionally substituted by halogen, trifluoromethyl, lower alkyl, lower alkoxy, nitro, amino, lower alkylamino and di(lower alkyl)amino. The compounds may be prepared by reacting a compound of the formula with an aromatizing agent, for the manufacture of an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group or B represents a lower alkoxy group esterifying an acid of Formula I in which R or R 1 represents a carboxy group or B represents a hydroxy group, for the manufacture of an acid of Formula I in which R or R 1 represents a carboxy group, R 3 represents a carboxy-(lower alkyl) group or B represents a hydroxy group hydrolysing an ester of Formula I in which R or R 1 represents a carbo-(lower alkoxy) group, R 3 represents a (lower alkoxycarbonyl)-(lower alkyl) group or B represents a lower alkoxy group, for the manufacture of a compound of Formula I in which R 1 represents an amino group reacting a compound of Formula I in which R 1 represents an acylamido group with an inorganic acid, if desired replacing a hydrogen atom denoted by R 3 in a compound of Formula I by an acyl or (lower alkoxycarbonyl)-(lower alkyl) group, for the manufacture of a compound of Formula I in which R or R 1 represents a di(lower alkyl)amino group alkylating a compound of Formula I in which R or R 1 represents an amino group, for the manufacture of a compound of Formula I in which R, R 1 or A represents a hydroxy group hydrolysing an ether of Formula I in which R, R 1 or A represents a lower alkoxy group, if desired converting a compound of Formula I in which A represents a hydroxy group into a compound of Formula I in which A represents a lower alkoxy, amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group, for the manufacture of an alcohol of Formula I in which A represents a hydroxy group reducing an ester of Formula I in which B represents a lower alkoxy group, if desired converting a hydroxy group denoted by B in an acid of Formula I or in a salt of such an acid with a base into an amino-(lower alkoxy), mono(lower alkyl)amino-(lower alkoxy) or di- (lower alkyl)amino-(lower alkoxy) group, for the manufacture of an optically active isomer of a compound of Formula I resolving a racemate of Formula I into its optically active isomers and isolating the desired isomer and for the manufacture of a salt of a compound of Formula I in which R or R 1 represents a carboxy group and/or B represents a hydroxy or carboxy group or in which R or R 1 represents an amino, mono(lower alkyl)amino or di(lower alkyl)amino group and/or B or A represents an amino-(lower alkoxy), mono(lower alkyl)amino- (lower alkoxy) or di(lower alkyl)amino-(lower alkoxy) group reacting such a compound of Formula I with a base or an acid. The compounds may be used as anti-inflammatory, analgesic and anti-rheumatic agents. [GB1385620A]
IE1252/73A 1972-07-24 1973-07-23 Carbazoles IE37942B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27414272A 1972-07-24 1972-07-24

Publications (2)

Publication Number Publication Date
IE37942L true IE37942L (en) 1974-01-24
IE37942B1 IE37942B1 (en) 1977-11-23

Family

ID=23046965

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1252/73A IE37942B1 (en) 1972-07-24 1973-07-23 Carbazoles

Country Status (26)

Country Link
JP (1) JPS5740144B2 (en)
KR (1) KR780000289B1 (en)
AR (1) AR205331A1 (en)
AT (1) AT325607B (en)
AU (1) AU475534B2 (en)
BE (1) BE802596A (en)
CA (1) CA1026348A (en)
CH (1) CH587819A5 (en)
DD (1) DD107681A5 (en)
DE (1) DE2337340C2 (en)
DK (1) DK138537B (en)
FI (1) FI59244C (en)
FR (1) FR2193611B1 (en)
GB (1) GB1385620A (en)
HK (1) HK49878A (en)
HU (1) HU167611B (en)
IE (1) IE37942B1 (en)
IL (1) IL42799A (en)
KE (1) KE2847A (en)
LU (1) LU68071A1 (en)
MY (1) MY7800315A (en)
NL (1) NL169877C (en)
NO (1) NO142865C (en)
SE (2) SE402283B (en)
SU (1) SU509220A3 (en)
ZA (1) ZA734047B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146542A (en) * 1978-06-12 1979-03-27 Hoffmann-La Roche Inc. Dihydrocarbazole acetic acid and esters thereof
US4150031A (en) * 1978-06-26 1979-04-17 Hoffmann-La Roche Inc. Hydroxy methyl carbazole acetic acid and esters
US4158007A (en) * 1978-08-21 1979-06-12 Hoffmann-La Roche Inc. Carbazole methyl malonates
US4501908A (en) * 1981-03-12 1985-02-26 Hoffmann-La Roche Inc. 2,3-Isopropylidene ribonic acid, 1,4-lactones
JPS6040256U (en) * 1983-08-25 1985-03-20 伊東 璋 Container cleaning machine
IL81325A (en) * 1986-01-23 1990-11-29 Merck Frosst Canada Inc Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them
ATE90076T1 (en) 1986-03-27 1993-06-15 Merck Frosst Canada Inc TETRAHYDROCARBAZOLE ESTER.
CA1326030C (en) * 1987-07-21 1994-01-11 John W. Gillard Cyclohept[b]indolealkanoic acids
EP0307077A1 (en) * 1987-07-21 1989-03-15 Merck Frosst Canada Inc. Tetrahydrocarbazoles for the improvement of cyclosporin therapy
PT95692A (en) * 1989-10-27 1991-09-13 American Home Prod PROCESS FOR THE PREPARATION OF INDOLE-, INDENO-, PYRANOINDOLE- AND TETRA-HYDROCARBAZOLE-ALCANOIC ACID DERIVATIVES, OR WHICH ARE USEFUL AS PLA2 INHIBITORS AND LIPOXIGENASE
US6013808A (en) * 1998-06-16 2000-01-11 Pfizer Inc. Method of purifying carbazole ester precursors of 6-chloro-α-methyl-carbazole-2-acetic acid
JP2004010601A (en) * 2002-06-11 2004-01-15 Nippon Steel Chem Co Ltd Process for producing indole derivative and useful intermediate therefor
JP2006517925A (en) * 2003-01-14 2006-08-03 メルク エンド カムパニー インコーポレーテッド Geminal disubstituted NSAID derivatives as Aβ42 lowering agents
KR101121819B1 (en) * 2003-05-06 2012-03-21 에어프로덕츠앤드케미칼스,인코포레이티드 Hydrogen storage by reversible hydrogenation of pi-conjugated substrates
US20070069197A1 (en) * 2003-08-15 2007-03-29 Universite Laval Monomers, oligomers and polymers of 2-functionalized and 2,7-difunctionalized carbzoles
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
WO2013072915A1 (en) * 2011-11-15 2013-05-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Tricyclic compounds, compositions comprising them and uses thereof
JP5940036B2 (en) * 2013-10-08 2016-06-29 テックフィールズ バイオケム カンパニー リミテッド Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin permeability
JP7747621B2 (en) * 2020-03-25 2025-10-01 Jnc株式会社 Compound, liquid crystal composition and liquid crystal display element

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (en) *
US3580926A (en) * 1969-11-10 1971-05-25 Parke Davis & Co Carbazole-4-alkanoic acids and tetrahydrocarbazole-4-alkanoic acids
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
ATA649773A (en) 1975-01-15
AU475534B2 (en) 1976-08-26
JPS4943973A (en) 1974-04-25
DK138537C (en) 1979-03-05
KE2847A (en) 1978-06-30
FI59244B (en) 1981-03-31
KR780000289B1 (en) 1978-08-10
IE37942B1 (en) 1977-11-23
BE802596A (en) 1974-01-21
ZA734047B (en) 1974-03-27
FR2193611A1 (en) 1974-02-22
NL7310275A (en) 1974-01-28
NL169877C (en) 1982-09-01
SE402283B (en) 1978-06-26
HK49878A (en) 1978-09-08
DK138537B (en) 1978-09-25
NO142865B (en) 1980-07-28
CA1026348A (en) 1978-02-14
JPS5740144B2 (en) 1982-08-25
HU167611B (en) 1975-11-28
IL42799A0 (en) 1973-10-25
CH587819A5 (en) 1977-05-13
DE2337340C2 (en) 1985-05-02
SU509220A3 (en) 1976-03-30
GB1385620A (en) 1975-02-26
IL42799A (en) 1977-03-31
AT325607B (en) 1975-10-27
LU68071A1 (en) 1975-04-11
NL169877B (en) 1982-04-01
FI59244C (en) 1981-07-10
AR205331A1 (en) 1976-04-30
MY7800315A (en) 1978-12-31
DD107681A5 (en) 1974-08-12
DE2337340A1 (en) 1974-02-14
NO142865C (en) 1980-11-05
AU5839073A (en) 1975-01-23
FR2193611B1 (en) 1976-05-14
SE7605813L (en) 1976-05-21

Similar Documents

Publication Publication Date Title
IE37942B1 (en) Carbazoles
KR970704663A (en) Retinoic acid X-receptor ligands (RETINOIC ACID X-RECEPTOR LIGANDS)
ES2173279T3 (en) METHOD FOR MAKING (S) -3- (AMINOMETILO) -5-METILOHEXANOIC ACID.
ES442684A1 (en) PROCEDURE FOR THE PREPARATION OF CARBAZOLES.
AU4893979A (en) Controlling parasites using 2-aryl-1,3-cyclohexanedione
GB1180873A (en) Amino-Esters of Substituted 4-Pentynoic-2-Acid, their Salification products and their method of manufacture
CO5720995A2 (en) NEW COMPOUND
IE800918L (en) Phenylethylamine derivatives
GB1285400A (en) Esters of substituted anthranilic acid
ES8307820A1 (en) Cephalosporin esters, process for their preparation and pharmaceutical compositions containing them.
AR018675A1 (en) DERIVATIVES OF 3- (2-OXO- [1,3¿I¿] BIPIRROLIDINIL-3-ILIDENOMETIL) -CEFEM, A PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
AU587873B2 (en) ((((3-pyridinyl)methylen)amino)oxy)alkanoic acids
EP0382114A3 (en) N-acyl-2-amino acid amides containing phosphinic-acid esters, process for their preparation and n-acyl-2-amino acid nitriles as starting products
IE33679B1 (en) 3-(3,4-dihydroxyphenyl)-alanine
DE3380024D1 (en) Process for the preparation of the 1'-ethoxycarbonyloxyethyl ester of benzylpenicillin
ES8304920A1 (en) A PROCEDURE FOR PREPARING N-ACIL-N-HYDROXY-A MINOACID DERIVATIVES.
ES8707193A1 (en) A METHOD FOR PRODUCING BROMODICLOROIMIDAZOLE DERIVATIVES
IE34145B1 (en) A process for the manufacture of amino acids and derivatives thereof
KR880011096A (en) Optically active oxo-isoindolinyl derivatives
GB1441941A (en) Process for the preparation of 5-substituted resorcinols and related intermediates
GB1382267A (en) Phenylalkanoic acid derivatives
GB1443647A (en) Imadazole derivatives and a process for the manufacture thereof
GB1251142A (en)
JPS5283436A (en) Preparation of intermediates for synthesis of prostaglandin
GB1413042A (en) Phenylalkenoic acid derivatives